CRISPR-Cas9 shows incredible promise, but the long term effects of cutting DNA in living organisms isn’t known. Now scientists from the Salk Institute have modified it to work without cutting, switching targeted genes on and off instead, and used it to treat diabetes and muscular dystrophy in mice.